Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429514
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2024-05-15
Brief Title:
Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression
Sponsor:
Ling Zhiqiang
Organization:
Zhejiang Cancer Hospital
Study Overview
Official Title:
Based on the Theory of Gut-brain Axis the Intervention Effect and Related Mechanism of Ganoderma Lucidum Spore Powder on Depressive Symptoms in Patients With Thyroid Cancer Were Investigated
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder
Detailed Description:
After being informed of the study and potential risks all patients who gave written informed consent were enrolled A total of 300 eligible patients were randomly assigned in a double-blind manner and divided into experimental group and control group at a ratio of 2 1 The subjects were given oral test drugs Ganoderma lucidum spore powder or placebo 4g per day for 90 days from the first day after enrollment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None